Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Total Valuation
Elanco Animal Health has a market cap or net worth of $4.70B. The enterprise value is $9.96B.
Market Cap$4.70B
Enterprise Value$9.96B
Share Statistics
Elanco Animal Health has 496,458,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding496,458,370
Owned by Insiders0.95%
Owned by Institutions1.16%
Financial Efficiency
Elanco Animal Health’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 1.53%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)1.53%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee493.22K
Profits Per Employee37.56K
Employee Count9,000
Asset Turnover0.35
Inventory Turnover1.61
Valuation Ratios
The current PE Ratio of Elanco Animal Health is 17.70. Elanco Animal Health’s PEG ratio is -0.14.
PE Ratio17.70
PS Ratio1.17
PB Ratio0.98
Price to Fair Value0.98
Price to FCF15.18
Price to Operating Cash Flow11.06
PEG Ratio-0.14
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.44B and earned 338.00M in profits. Earnings per share was 0.68.
Revenue4.44B
Gross Profit1.91B
Operating Income251.00M
Pretax Income488.00M
Net Income338.00M
EBITDA1.39B
Earnings Per Share (EPS)0.68
Cash Flow
In the last 12 months, operating cash flow was 541.00M and capital expenditures -153.00M, giving a free cash flow of 388.00M billion.
Operating Cash Flow541.00M
Free Cash Flow388.00M
Free Cash Flow per Share0.78
Dividends & Yields
Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.42
52-Week Price Change-30.29%
50-Day Moving Average10.19
200-Day Moving Average12.43
Relative Strength Index (RSI)50.09
Average Volume (3m)5.22M
Important Dates
Elanco Animal Health upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
Elanco Animal Health as a current ratio of 2.44, with Debt / Equity ratio of 70.88%
Current Ratio2.44
Quick Ratio1.25
Debt to Market Cap0.72
Net Debt to EBITDA2.78
Interest Coverage Ratio1.07
Taxes
In the past 12 months, Elanco Animal Health has paid 150.00M in taxes.
Income Tax150.00M
Effective Tax Rate0.31
Enterprise Valuation
Elanco Animal Health EV to EBITDA ratio is 7.10, with an EV/FCF ratio of 24.96.
EV to Sales2.22
EV to EBITDA7.10
EV to Free Cash Flow24.96
EV to Operating Cash Flow18.18
Balance Sheet
Elanco Animal Health has $468.00M in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.85B billion.
Cash & Marketable Securities$468.00M
Total Debt$0.00
Net Cash$3.85B
Net Cash Per Share$7.76
Tangible Book Value Per Share-$4.05
Margins
Gross margin is 46.00%, with operating margin of 5.65%, and net profit margin of 7.61%.
Gross Margin46.00%
Operating Margin5.65%
Pretax Margin10.99%
Net Profit Margin7.61%
EBITDA Margin31.20%
EBIT Margin16.29%
Analyst Forecast
The average price target for Elanco Animal Health is $13.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.83
Price Target Upside46.19% Upside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast0.50%
EPS Growth Forecast―